-
My Account
In App
My Account
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 20 | 45.71 | 45.75 | 583 |
| 410 | 45.70 | 45.80 | 50 |
| 2 | 45.68 | 45.82 | 1 |
| 100 | 45.67 | 45.89 | 100 |
| 100 | 45.66 | 45.93 | 100 |
| 0 | Total | Total | 0 |
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 20 | 45.71 | 45.75 | 583 |
| 410 | 45.70 | 45.80 | 50 |
| 2 | 45.68 | 45.82 | 1 |
| 100 | 45.67 | 45.89 | 100 |
| 100 | 45.66 | 45.93 | 100 |
| 0 | Total | Total | 0 |
| Open | 46.19 |
| Previous Close | 46.28 |
| Volume | 1,053,766.00 |
| Value (Lacs) | 481.68 |
| VWAP | 45.86 |
| Beta | |
| Mkt Cap (Rs. Cr.) | 2,505 |
| High | 46.44 |
| Low | 45.61 |
| UC Limit | 55.53 |
| LC Limit | 37.02 |
| 52 Week High | 91.70 |
| 52 Week Low | 42.00 |
| Face Value | 2.00 |
| All Time High | 840.00 |
| All Time Low | 2.05 |
| 20D Avg Volume | 1,310,110 |
| 20D Avg Delivery(%) | 46.72 |
| Book Value Per Share | 21.10 |
| Dividend Yield | 0.44 |
| TTM EPS See historical trend | 1.80 (-24.87% YoY) |
| TTM PE See historical trend | 25.39 (Low PE) |
| P/B See historical trend | 2.17 (Low P/B) |
| Sector PE | 40.31 |
*Delayed by 20 seconds.
Stock Score
Get detailed analysis with Moneycontrol Stock Insights.
| Moving Averages | -- |
| Technical Indicators | -- |
| Moving Averages Crossovers | -- |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| Days | |
|---|---|
| 5 | - - |
| 10 | - - |
| 20 | - - |
| 50 | - - |
| 100 | - - |
| 200 | - - |
| Moving Averages | -- |
| Technical Indicators | -- |
| Moving Averages Crossovers | -- |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| Days |
|---|
| Moving Averages | -- |
| Technical Indicators | -- |
| Moving Averages Crossovers | -- |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| Days |
|---|
| 1 Week | --% | |
| 1 Month | --% | |
| 3 Months | --% | |
| YTD | --% | |
| 1 Year | --% | |
| 3 Years | --% |
9 out of 17 years Morepen Laboratories has given negative returns in November.
| Month | Max. Positive Change(%) | Avg. Positive Change(%) | Max. Negative Change(%) | Avg. Negative Change(%) | Average Change(%) |
|---|---|---|---|---|---|
| November | 38.11% (2015) | 20.57% | -19.42% (2014) | -8.11% | 5.39% |
Morepen Lab Standalone June 2025 Net Sales at Rs 391.28 crore, up 1.46% Y-o-Y Aug 07 2025 11:01 AM
Morepen Labs to Consider Q1 FY26 Results & Dividend on August 6 Aug 01 2025 03:54 PM
Trade Spotlight: How should you trade Grindwell Norton, Morepen Labs, Astral, Aditya Birla Capital, Pfizer, Clean Science and others on May 23? May 22 2025 08:04 PM
Morepen Lab Standalone March 2025 Net Sales at Rs 381.94 crore, down 2.72% Y-o-Y May 13 2025 11:43 AM
The current year 2025 is going well for many companies who launched IPO. During this high current season for launching IPOs, these gentlemen taken their step back to launch devices IPO. No one knows when they are planning to launch it. Still are they exercising to increase their stake at cheaper price to gain maximum advantage. Till the announcement is made the stock price seems to be range bounded. View more
Posted by : SPEN
Repost this message
The current year 2025 is going well for many companies who launched IPO. During this high current season for launching IPOs, these gentlemen taken their step back to launch devices IPO. No one knows when they are planning to launch it. Still are they exercising to increase their stake at cheaper price to gain maximum advantage. Till the announcement is made the stock price seems to be range bounded.
Posted by : The Fixed Income
Repost this message
A High-Return PSU Bond for Stable Wealth Growth 9.42% KERALA INFRASTRUCTURE INVESTMENT FUND BOARD 2034 ✔️ Coupon: 9.42% ✔️ Rating: INDIA RATING AA(CE) Stable, Acuite AA(CE) Stable ✔️ Tenor: 9y 1m PSU Bond | High Return Bond | Listed This KIIFB bond adds a layer of stability to your portfolio with state-backed assurance and consistent long-term returns. ???? Explore on The Fixed Income: https://www.thefixedincome.com/product/dVJLdlpnPT0=/942-kerala-infrastructure-investment-fund-board-2034?utm_source=Moneycontrol&utm_medium=Forum&utm_campaign=Product_list
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
| Qty 3077570 | Price 62.36 | % Traded 0.56 |
| Qty 3077570 | Price 62.4 | % Traded 0.56 |
| Qty 4332551 | Price 60.53 | % Traded 0.77 |
| Qty 4332551 | Price 60.5 | % Traded 0.77 |
| Qty 3617786 | Price 47.96 | % Traded 0.65 |
| Qty 3617786 | Price 47.98 | % Traded 0.65 |
| Qty 2906229 | Price 83.13 | % Traded 0.55 |
| Qty 2906229 | Price 83.04 | % Traded 0.55 |
*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.
| Date | Agenda |
|---|
| Ex-Date | Type | Dividend (Rs) |
|---|
| Announcement Date | Ex-Bonus | Ratio |
|---|
| Ex-Split | Old FV | New FV |
|---|
| Ex-Right | Ratio | Premium |
|---|
| Date | Agenda |
|---|
| Company Name | Price | % Chg | MCap(Cr) | TTM PE | P/B | ROE(%) | 1 Yr Perform(%) | Net Profit(Rs.) | Net Sales(Rs.) | Debt to Equity |
|---|---|---|---|---|---|---|---|---|---|---|
| Morepen Lab | 45.71 | -1.23 | 2,504.70 | 25.39 | 2.17 | 10.20 | -38.35 | 118 | 1,811 | 0.07 |
| Sun Pharma | 1,758.80 | -0.29 | 421,995.03 | 40.39 | 5.84 | 15.13 | 0.63 | 10,980 | 52,578 | 0.03 |
| Divis Labs | 6,473.50 | -0.69 | 171,851.09 | 69.15 | 11.48 | 14.63 | 12.26 | 2,191 | 9,360 | 0.00 |
| Torrent Pharma | 3,790.80 | -0.75 | 128,297.90 | 59.95 | 17.10 | 25.17 | 22.06 | 1,911 | 11,516 | 0.40 |
| Cipla | 1,514.50 | -1.37 | 122,336.95 | 22.48 | 3.92 | 16.90 | 3.36 | 5,291 | 27,547 | 0.00 |
Sharpest Opinions & Actionable Insights 
Exclusive Webinars 
Research & Expert Technical Analysis 
